Document is current

Any future updates will be listed below

Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study

Crossref DOI link: https://doi.org/10.1186/s12913-015-0971-4

Published Online: 2015-08-05

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark